{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:26:38Z","timestamp":1783445198794,"version":"3.54.6"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02441-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:23Z","timestamp":1777417163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic markers of kidney function and oxidative stress are associated with heart failure with preserved ejection fraction (HFpEF) in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)"],"prefix":"10.1007","volume":"22","author":[{"given":"Kara","family":"Wegermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Coulter","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Newgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhiy","family":"Hnatyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petia","family":"Shipkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svati H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Moylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"3","key":"2441_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1021\/acs.chemrev.7b00181","volume":"118","author":"I Ali","year":"2018","unstructured":"Ali, I., et al. (2018). Lysine acetylation goes global: From epigenetics to metabolism and therapeutics. Chemical Reviews, 118(3), 1216\u20131252.","journal-title":"Chemical Reviews"},{"key":"2441_CR25","doi-asserted-by":"crossref","unstructured":"Alrob, O. A., et al. (2014). Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovascular Research, 103(4), 485\u2013497.","DOI":"10.1093\/cvr\/cvu156"},{"issue":"12","key":"2441_CR49","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/ejhf.2064","volume":"22","author":"SD Anker","year":"2020","unstructured":"Anker, S. D., et al. (2020). Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial. European Journal Of Heart Failure, 22(12), 2383\u20132392.","journal-title":"European Journal Of Heart Failure"},{"issue":"9","key":"2441_CR56","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s12276-022-00803-2","volume":"54","author":"H Bae","year":"2022","unstructured":"Bae, H., Lam, K., & Jang, C. (2022). Metabolic flux between organs measured by arteriovenous metabolite gradients. Experimental & Molecular Medicine, 54(9), 1354\u20131366.","journal-title":"Experimental & Molecular Medicine"},{"key":"2441_CR16","doi-asserted-by":"crossref","unstructured":"Beretta, L., & Santaniello, A. (2016). Nearest neighbor imputation algorithms: a critical evaluation. BMC Medical Informatics and Decision Making, 16(Suppl 3), 74.","DOI":"10.1186\/s12911-016-0318-z"},{"key":"2441_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3567","author":"KC Chang","year":"2025","unstructured":"Chang, K. C., et al. (2025). Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure. European Journal Of Heart Failure. https:\/\/doi.org\/10.1002\/ejhf.3567","journal-title":"European Journal Of Heart Failure"},{"issue":"13","key":"2441_CR36","first-page":"7433","volume":"24","author":"Y Chang","year":"2020","unstructured":"Chang, Y., et al. (2020). A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease. European Review For Medical And Pharmacological Sciences, 24(13), 7433\u20137441.","journal-title":"European Review For Medical And Pharmacological Sciences"},{"issue":"3","key":"2441_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","volume":"74","author":"M Dambrova","year":"2022","unstructured":"Dambrova, M., et al. (2022). Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacological Reviews, 74(3), 506\u2013551.","journal-title":"Pharmacological Reviews"},{"issue":"5","key":"2441_CR41","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","volume":"154","author":"K Du","year":"2018","unstructured":"Du, K., et al. (2018). Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Gastroenterology, 154(5), 1465\u20131479e13.","journal-title":"Gastroenterology"},{"issue":"1","key":"2441_CR38","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.1038\/s41598-019-47216-2","volume":"9","author":"K Enooku","year":"2019","unstructured":"Enooku, K., et al. (2019). Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Scientific Reports, 9(1), 10663.","journal-title":"Scientific Reports"},{"issue":"22","key":"2441_CR1","doi-asserted-by":"publisher","first-page":"e021654","DOI":"10.1161\/JAHA.121.021654","volume":"10","author":"M Fudim","year":"2021","unstructured":"Fudim, M., et al. (2021). Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries. Journal of the American Heart Association, 10(22), e021654.","journal-title":"Journal of the American Heart Association"},{"key":"2441_CR23","doi-asserted-by":"crossref","unstructured":"Fu, Q., Cat, A., & Zheng, Y. G. (2023). New histone lysine acylation biomarkers and their roles in epigenetic regulation. Current Protocols, 3(4), e746.","DOI":"10.1002\/cpz1.746"},{"key":"2441_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms241814292","volume":"24","author":"A Goliopoulou","year":"2023","unstructured":"Goliopoulou, A., et al. (2023). Non-alcoholic fatty liver disease and echocardiographic parameters of left ventricular diastolic function: A Systematic review and meta-analysis. International Journal Of Molecular Sciences, 24, 18.","journal-title":"International Journal Of Molecular Sciences"},{"key":"2441_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/jci.insight.159204","volume":"7","author":"T Grenier-Larouche","year":"2022","unstructured":"Grenier-Larouche, T. (2022). Altered branched-chain alpha-keto acid metabolism is a feature of NAFLD in individuals with severe obesity. JCI Insight, 7, 15.","journal-title":"JCI Insight"},{"issue":"12","key":"2441_CR46","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cardfail.2020.07.010","volume":"26","author":"C Hage","year":"2020","unstructured":"Hage, C., et al. (2020). Metabolomic Profile in HFpEF vs HFrEF Patients. Journal Of Cardiac Failure, 26(12), 1050\u20131059.","journal-title":"Journal Of Cardiac Failure"},{"issue":"2","key":"2441_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","volume":"143","author":"VS Hahn","year":"2021","unstructured":"Hahn, V. S., et al. (2021). Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. Circulation, 143(2), 120\u2013134.","journal-title":"Circulation"},{"issue":"15","key":"2441_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","volume":"147","author":"VS Hahn","year":"2023","unstructured":"Hahn, V. S., et al. (2023). Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction. Circulation, 147(15), 1147\u20131161.","journal-title":"Circulation"},{"key":"2441_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/JAHA.115.003190","volume":"5","author":"WG Hunter","year":"2016","unstructured":"Hunter, W. G., et al. (2016). Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure. J Am Heart Assoc, 5, 8.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2441_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2018.10.059","volume":"73","author":"WG Hunter","year":"2019","unstructured":"Hunter, W. G., et al. (2019). High-density lipoprotein particle subfractions in heart failure with preserved or reduced ejection fraction. Journal Of The American College Of Cardiology, 73(2), 177\u2013186.","journal-title":"Journal Of The American College Of Cardiology"},{"issue":"3","key":"2441_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan, S. C., et al. (2011). Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism, 60(3), 404\u2013413.","journal-title":"Metabolism"},{"key":"2441_CR15","doi-asserted-by":"publisher","first-page":"155666","DOI":"10.1016\/j.metabol.2023.155666","volume":"147","author":"M Kouvari","year":"2023","unstructured":"Kouvari, M., et al. (2023). Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study. Metabolism, 147, 155666.","journal-title":"Metabolism"},{"issue":"11","key":"2441_CR20","doi-asserted-by":"publisher","first-page":"e1005553","DOI":"10.1371\/journal.pgen.1005553","volume":"11","author":"WE Kraus","year":"2015","unstructured":"Kraus, W. E., et al. (2015). Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis. Plos Genetics, 11(11), e1005553.","journal-title":"Plos Genetics"},{"key":"2441_CR12","doi-asserted-by":"crossref","unstructured":"Lee, J. H., et al. (2010). Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digestive And Liver Disease Official Journal Of The Italian Society Of Gastroenterology And The Italian Association For The Study Of The Liver, 42(7), 503\u2013508.","DOI":"10.1016\/j.dld.2009.08.002"},{"issue":"1","key":"2441_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12872-021-02209-w","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu, J., et al. (2021). Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats. Bmc Cardiovascular Disorders, 21(1), 403.","journal-title":"Bmc Cardiovascular Disorders"},{"issue":"1","key":"2441_CR35","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1038\/s41467-024-50125-2","volume":"15","author":"J Lv","year":"2024","unstructured":"Lv, J., et al. (2024). Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nature Communications, 15(1), 5729.","journal-title":"Nature Communications"},{"issue":"2","key":"2441_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","volume":"17","author":"M Masarone","year":"2021","unstructured":"Masarone, M., et al. (2021). Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics, 17(2), 12.","journal-title":"Metabolomics"},{"issue":"1","key":"2441_CR6","doi-asserted-by":"publisher","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","volume":"10","author":"A Miller","year":"2020","unstructured":"Miller, A., et al. (2020). Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. Scientific Reports, 10(1), 12440.","journal-title":"Scientific Reports"},{"issue":"6514","key":"2441_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","volume":"370","author":"D Murashige","year":"2020","unstructured":"Murashige, D., et al. (2020). Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science, 370(6514), 364\u2013368.","journal-title":"Science"},{"issue":"7","key":"2441_CR53","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso, G., et al. (2014). Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. Plos Medicine, 11(7), e1001680.","journal-title":"Plos Medicine"},{"issue":"10","key":"2441_CR54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","volume":"21","author":"G Musso","year":"2015","unstructured":"Musso, G., et al. (2015). Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. Trends In Molecular Medicine, 21(10), 645\u2013662.","journal-title":"Trends In Molecular Medicine"},{"issue":"3","key":"2441_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacbts.2023.11.006","volume":"9","author":"JF O\u2019Sullivan","year":"2024","unstructured":"O\u2019Sullivan, J. F., Koay, L. M., Wang, Y. C., Guglielmi, X. S., Marques, G., Nanayakkara, F. Z., Mariani, S., Slaughter, J. E., and, & Kaye, D. M. (2024). Cardiac substrate utilization and relationship to invasive exercise hemodynamic parameters in HFpEF. Basic to Translational Science, 9(3), 281\u2013299.","journal-title":"Basic to Translational Science"},{"issue":"12","key":"2441_CR48","doi-asserted-by":"publisher","first-page":"100705","DOI":"10.1016\/j.xkme.2023.100705","volume":"5","author":"RN Patel","year":"2023","unstructured":"Patel, R. N., et al. (2023). Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder. Kidney Med, 5(12), 100705.","journal-title":"Kidney Med"},{"issue":"7","key":"2441_CR47","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","volume":"310","author":"RE Patterson","year":"2016","unstructured":"Patterson, R. E., et al. (2016). Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. American Journal Of Physiology. Endocrinology And Metabolism, 310(7), E484\u2013E494.","journal-title":"American Journal Of Physiology. Endocrinology And Metabolism"},{"key":"2441_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E., et al. (2023). AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"issue":"6","key":"2441_CR13","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E., et al. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78(6), 1966\u20131986.","journal-title":"Hepatology"},{"key":"2441_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E., et al. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"2441_CR7","doi-asserted-by":"crossref","unstructured":"Salah, H. M., et al. (2021). Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction. JACC Basic to Translational Science, 6(11), 918\u2013932.","DOI":"10.1016\/j.jacbts.2021.07.010"},{"issue":"2","key":"2441_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/jcm9020314","volume":"9","author":"Y Sandlers","year":"2020","unstructured":"Sandlers, Y. (2020). Plasma Krebs cycle intermediates in nonalcoholic fatty liver disease. Journal of Clinical Medicine, 9(2), 314.","journal-title":"Journal of Clinical Medicine"},{"key":"2441_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/msb.2009.11","volume":"5","author":"SH Shah","year":"2009","unstructured":"Shah, S. H., et al. (2009). High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Molecular Systems Biology, 5, 258.","journal-title":"Molecular Systems Biology"},{"key":"2441_CR17","doi-asserted-by":"crossref","unstructured":"Shah, S. H., et al. (2010). Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circulation Cardiovascular Genetics, 3(2), 207\u2013214.","DOI":"10.1161\/CIRCGENETICS.109.852814"},{"issue":"7","key":"2441_CR50","doi-asserted-by":"publisher","first-page":"e004962","DOI":"10.1161\/CIRCHEARTFAILURE.118.004962","volume":"11","author":"SD Solomon","year":"2018","unstructured":"Solomon, S. D., et al. (2018). Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circulation. Heart Failure, 11(7), e004962.","journal-title":"Circulation. Heart Failure"},{"issue":"17","key":"2441_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon, S. D., et al. (2019). Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction. New England Journal Of Medicine, 381(17), 1609\u20131620.","journal-title":"New England Journal Of Medicine"},{"issue":"6","key":"2441_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K., et al. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology, 43(6), 1317\u20131325.","journal-title":"Hepatology"},{"key":"2441_CR21","unstructured":"Stevens, J. (1992). Applied Multivariate Statistics for the Social Sciences. Lawrence Erlbaum Associates."},{"issue":"21","key":"2441_CR28","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun, H., et al. (2016). Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation, 133(21), 2038\u20132049.","journal-title":"Circulation"},{"issue":"6","key":"2441_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny, N. E., et al. (2011). Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab, 14(6), 804\u2013810.","journal-title":"Cell Metab"},{"issue":"7","key":"2441_CR55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher, G., Valenti, L., & Byrne, C. D. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease. New England Journal Of Medicine, 393(7), 683\u2013698.","journal-title":"New England Journal Of Medicine"},{"issue":"1","key":"2441_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-021-01353-z","volume":"20","author":"LK Truby","year":"2021","unstructured":"Truby, L. K., et al. (2021). Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy. Cardiovasc Diabetol, 20(1), 161.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2441_CR52","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani, S. S., et al. (2021). Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation, 143(8), e254\u2013e743.","journal-title":"Circulation"},{"issue":"1","key":"2441_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ehf2.14211","volume":"10","author":"A Wang","year":"2023","unstructured":"Wang, A., et al. (2023). Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics. ESC Heart Fail, 10(1), 416\u2013431.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"2441_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1086\/512981","volume":"80","author":"L Wang","year":"2007","unstructured":"Wang, L., et al. (2007). Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. American Journal Of Human Genetics, 80(4), 650\u2013663.","journal-title":"American Journal Of Human Genetics"},{"issue":"9","key":"2441_CR32","doi-asserted-by":"publisher","first-page":"e0204308","DOI":"10.1371\/journal.pone.0204308","volume":"13","author":"K Wegermann","year":"2018","unstructured":"Wegermann, K., et al. (2018). Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study. PLoS One, 13(9), e0204308.","journal-title":"PLoS One"},{"key":"2441_CR22","doi-asserted-by":"crossref","unstructured":"Wegermann, K., et al. (2023). Serum metabolites are associated with HFpEF in biopsy-proven nonalcoholic fatty liver disease. Journal of the American Heart Association, 12(14), e029873.","DOI":"10.1161\/JAHA.123.029873"},{"issue":"1","key":"2441_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","volume":"8","author":"R Wei","year":"2018","unstructured":"Wei, R., et al. (2018). Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data. Scientific Reports, 8(1), 663.","journal-title":"Scientific Reports"},{"issue":"3","key":"2441_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacbts.2016.11.009","volume":"2","author":"AR Wende","year":"2017","unstructured":"Wende, A. R., et al. (2017). Metabolic origins of heart failure. JACC Basic to Translational Science 2(3), 297\u2013310.","journal-title":"JACC Basic to Translational Science"},{"issue":"4","key":"2441_CR51","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ekir.2022.01.1067","volume":"7","author":"LR Zelnick","year":"2022","unstructured":"Zelnick, L. R., et al. (2022). Prediction of incident heart failure in CKD: The CRIC study. Kidney International Reports, 7(4), 708\u2013719.","journal-title":"Kidney International Reports"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02441-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:04:42Z","timestamp":1783443882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2441"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02441-5","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}